US tax reform: Implications for pharma and life sciences
- 1 Minute Lesezeit
In December 2017, the United States enacted the most comprehensive tax reform in more than 30 years. For the pharmaceutical and life sciences sector, the changes will impact both US and non-US headquartered companies doing business in the United States.
Weiterlesen mit einem PwC Plus-Abonnement
- qualitätsgesicherte Quellen
- tägliche Updates
- vollständige Filterfunktion von Artikeln
- Verteilung via anpassbarem Alert